846
Views
47
CrossRef citations to date
0
Altmetric
Original Research

Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles

, , , , , & show all
Pages 669-677 | Published online: 13 Sep 2010

References

  • SzebeniJMuggiaFMAlvingCRComplement activation by cremophor EL as a possible contributor to hypersensitivity to paclitaxel: An in vitro studyJ Natl Cancer Inst19989043003069486816
  • MichaudLBValeroVHortobagyiGRisks and benefits of taxanes in breast and ovarian cancerDrug Saf200023540142811085347
  • DosioFBrusaPCrosassoPArpiccoSCattelLPreparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugateJ Control Release1997473293304
  • SkwarczynskiMHayashiYKisoYPaclitaxel prodrugs: Toward smarter delivery of anticancer agentsJ Med Chem200649257253726917149855
  • MarupudiNIHanJELiKWPaclitaxel: A review of adverse toxicities and novel delivery strategiesExpert Opin Drug Saf20076560962117877447
  • DesaiNTeieuVYaoZIncreased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxelClin Cancer Res20061241317132416489089
  • GradisharWJTjulandinSDavodsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
  • HuhKMLeeSCChoYWLeeJJeongJHParkKHydrotropic polymer micelle system for delivery of paclitaxelJ Control Release20051011–35668
  • SuhHJeongBRathiRKimSWRegulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheresJ Biomed Mater Res19984223313389773830
  • SeowWYXueJMYangYYTargeted and intracellular delivery of paclitaxel using multi-functional polymeric micellsBiomaterials20072891730174017182095
  • ZhangYTangLSunLA novel paclitaxel-loaded poly-(ɛ-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatmentActa Biomater2010662045205219969111
  • TemmingKMeyerDLZabinskiREvaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vesselsBioconjug Chem20061761385139417105215
  • TemmingKMeyerDLZabinskiRImproved efficacy αvβ3-targeted albumin conjugates by conjugation of a novel auristatin derivativeMol Pharm20074568669417683157
  • RahimnejadMJahanshahiMNajafpourGDProduction of biological nanoparticles from bovine serum albumin for drug deliveryAfr J Biotechnol200652019181923
  • GreenMRManikhasGMOrlovSAfanasyevBMakhsonAMAbraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancerAnn Oncol20061781263126816740598
  • MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
  • GradisharWJAlbumin-bound paclitaxel: A next-generation taxaneExpert Opin Pharmacother2006781041105316722814
  • GrunerBAWeitmanSDThe folate receptor as a potential therapeutic anticancer targetInvest New Drugs199916320521910360600
  • LuYLowPSFolate-mediated delivery of macromolecular anticancer therapeutic agentsAdv Drug Deliv Rev200254567569312204598
  • SabharanjakSMayorSFolate receptor endocytosis and traffickingAdv Drug Deliv Rev20045681099110915094209
  • ZhengYSongSGDarbyMPreparation and characterization of folate-poly(ethylene glycol)-grafted-trimethylchitosan for intracellular transport of protein through folate receptor-mediated endocytosisJ Biotechnol20091451475319770010
  • DosioFArpicoSStellaBBrusaPCattelLFolate-mediated targeting of albumin conjugates of paclitaxel obtained through a heterogeneous phase systemInt J Pharm20093821–211712319712735
  • LiFQSuHWangJLiuYJPreparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for live targetingInt J Pharm20083491–227428217870261
  • WeberCCoesterCKeruterJLangerKDesolvation process and surface characterization of protein nanoparticlesInt J Pharm200019419110210601688
  • ZuYZhangYZhaoXZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine2009432133320054435
  • LeeRLowPDelivery of liposomes into cultured KB cells via folate receptor mediated endocytosisJ Biol Chem19942695319832048106354
  • ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
  • MezianiMJSunYPProtein-conjugated nanoparticles from rapid expansion of supercritical fluid solution into aqueous solutionJ Am Chem Soc2003125268015801812823024
  • MerodioMArnedoARenedoMJIracheJMGanciclovir-loaded albumin nanoparticles: Characterization and in vitro release propertiesEur J Pharm Sci200112325125911113644
  • ChoWYLeeJLeeSCHuhKMParkKHydrotropic agents for study of in vitro paclitaxel release from polymeric micellesJ Control Release200497224925715196752
  • HattoriYMaitaniYEnhanced in vitro DNA transfection efficiency by novel folate-linked nanoparicles in human prostate cancer and oral cancerJ Control Release200497117318315147814
  • HolmJHansenSIHoier-MadsenMHigh-affinity folate binding in human prostateBiosci Rep1993132991058374062
  • HattoriYMaitaniYFolate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinaseCancer Gene Ther2005121079680915891776
  • PaalKMullerJHegedusLHigh affinity binding of paclitaxel to human serum albuminEur J Biochem200126872187219111277943
  • HaleyBFrenkelENanoparticles for drug delivery in cancer treatmentUrol Oncol2008261576418190833